Insects mount a robust innate immune response against a wide array of microbial pathogens. The hallmark of the Drosophila humoral immune response is the rapid production of antimicrobial peptides in the fat body and their release into the circulation. Two recognition and signaling cascades regulate expression of these antimicrobial peptide genes. The Toll pathway is activated by fungal and many Gram-positive bacterial infections, whereas the immune deficiency (IMD) pathway responds to Gram-negative bacteria. Recent work has shown that the intensity and duration of the Drosophila immune response is tightly regulated. As in mammals, hyperactivated immune responses are detrimental, and the proper down-modulation of immunity is critical for protective immunity and health. In order to keep the immune response properly modulated, the Toll and IMD pathways are controlled at multiple levels by a series of negative regulators. In this review, we focus on recent advances identifying and characterizing the negative regulators of these pathways.
Insects rely primarily on innate immune responses to fight pathogens and have developed multiple mechanisms to recognize and respond to infection. The insect and mammalian innate immune responses exhibit a great deal of evolutionary conservation. One of the best examples of this conservation was provided by the discovery of the Toll pathway as a key component of the Drosophila immune response and the subsequent identification of the mammalian Toll-like Receptors (TLRs). In addition, the insect immune response relies on evolutionarily conserved NF-κB signaling cascades for the control of immune-induced gene expression. The genetic, genomic, and molecular tools available for studying the immune response in the fruit fly Drosophila melanogaster make this a favorite model system (1) (2) (3) (4) . Drosophila use several distinct effector mechanisms for immune protection including clotting, melanization, encapsulation, cell-based phagocytosis, and the inducible production of a battery of antimicrobial peptides. This antimicrobial peptide response is critical for protection against many microbial pathogens. Two signaling pathways regulate the production of these antimicrobial peptides in Drosophila -the immune deficiency (IMD) and Toll pathways. Recent work has shown that the intensity and duration of immune response is tightly regulated in Drosophila. As in mammals, over-exuberant immune responses are detrimental, and the proper down modulation of immunity is critical for health. In this review, we focus on the negative regulation of the IMD and the Toll pathway.
Overview of Drosophila immune signaling
Before discussing in detail the recent advances in the downregulation of innate immune signaling in Drosophila, we will first provide an overview of the Toll and IMD pathways. For bacterial recognition, both of these pathways rely on Peptidoglycan Recognition Proteins (PGRPs). Drosophila encode 13 PGRP genes that are spliced into at least 17 PGRP proteins (5) . The Drosophila PGRPs can be classified as either short PGRP proteins (seven different genes, seven proteins) or long PGRP proteins, with extended N-termini (ten genes, thirteen proteins) (5) . Most short PGRP proteins have a signal sequence, lack a transmembrane domain, and are likely to be secreted (PGRP-SA, -SB1, -SB2, -SC1a, -SC1b, -SC2, -SD). Some long PGRP proteins are transmembrane proteins with a single-pass transmembrane domain (PGRP-LAa, -LAb, -LCa, -LCx, -LCy, -LD, -LF). However, some long PGRP proteins lack both a signal peptide and a transmembrane domain (-LAc, -LB, -LE), and are likely intracellular proteins, or they could be secreted by a non-canonical mechanism (6). PGRP-SA and -SD are involved in bacterial recognition in the Toll pathway, while PGRP-LC and -LE are involved in bacterial recognition in the IMD pathway. In addition, at least two members of the Gram-negative binding protein (GNBP) family are involved in the Toll pathway, as detailed below (7) (8) (9) . Interestingly, some of the other PGRPs (i.e. PGRP-LB, and -SC1) are enzymes that degrade peptidoglycan, an activity that is important for down-regulating immune responses (see below for more details) (10, 11) . http://bmbreports.org 
The Toll pathway
The Toll pathway responds to Gram-positive bacterial and fungal infections in addition to its role in establishing the dorsal-ventral pattern of the early embryo (12) . Unlike human Toll-like receptors (TLRs) Drosophila Toll does not directly bind pathogens or pathogen-derived compounds. Instead, Toll is a cytokine receptor, activated by the cytokine Spätzle. Spätzle is produced as a pro-protein, with a disulfide-linked dimeric structure. In order to activate the Toll pathway, pathogens must first activate serine protease cascades that culminate in Spätzle cleavage, liberating the mature Toll ligand (C-terminal 106 amino acids of Spätzle) (13) (14) (15) . Therefore, microbial recognition must occur upstream of protease activation, Spätzle cleavage and Toll activation. Recognition of bacteria and fungi involve three distinct pathways that converge on Spätzle cleavage.
Recognition of Gram-positive bacteria is mediated through the detection of lysine-containing peptidoglycan (PGN) by PGRP-SA and PGRP-SD (16, 17) . In addition, PGRP-SA functions in a complex with Gram-negative binding protein 1 (GNBP-1) (8, 9) , which is believed to function as a PGN processing enzyme (18) . Bacterial recognition in the Toll pathway also requires the serine protease Grass, which is thought to function downstream of these PGN receptors (15) .
On the other hand, detection of fungal infections relies on two additional detection systems. In one pathway, fungal betaglucans are recognized by the receptor GNBP-3 (7). Another pathway involves a serine protease known as Persephone (PSH). psh mutants were first discovered as suppressors of the necrotic (nec) phenotype (19) . nec encodes a serine protease inhibitor of the serpin family and lack of nec leads to constitutive activation of the Toll pathway in a psh-dependent manner (19, 20) . Live, entomopathogenic molds, such as B. bassiana and M. anisopliae stimulate the PSH pathway independently of GNBP3-mediated recognition, while yeast or killed molds activate only the GNBP3-dependent pathway. Instead of relying on a pattern recognition receptor, the PSH-dependent pathway is probably stimulated directly by pathogen-produced proteases, such as PR1A from M. anisopliae, that are released by entomopathogenic fungi to break through the host cuticle (7) .
Once activated, PGRP-SA/GNBP1, PGRP-SD, GNBP3 or PSH lead to Spätzle cleavage by activating serine protease cascades that converge on two chymotrypsin-like serine proteases: Spirit and the Spätzle-processing enzyme (SPE) (15, 21) . SPE cleaves Spätzle directly, while Spirit is thought to cleave and activate SPE. In the bacterial pathway the Grass serine protease is thought to trigger Spirit, and in one fungal pathway PSH is believed to be upstream of Spirit, while in the GNBP3/fungal pathway the upstream protease(s) are not yet identified (7, 15 ) (see Fig. 1 . for model).
Once cleaved, Spätzle binds the Toll receptor and induces dimerization. Although the ligand is a symmetric dimer, biophysical studies indicate that the Spätzle-induced Toll dimer is asymmetrical (14) . Dimerization of the Toll receptor is believed to recruit a pre-existing Myd88/Tube complex that ultimately recruits the kinase Pelle, which is homologous to the mammalian IRAK family of kinases (22) (23) (24) . Activation of the Pelle kinase leads to the phosphorylation and ubiquitin/protesome-mediated degradation of Cactus, the Drosophila IκB homolog (25) . It is not yet clear which kinase directly phosphorylates Cactus, but degradation of Cactus frees DIF (and Dorsal) to translocate to the nucleus (26) (27) (28) (29) (30) , and leads directly to the transcriptional induction of many immune responsive genes like the AMP genes Defensin, Drosomycin, Cecropin and Metchnikowin (31) (32) (33) . The intracellular components of the Drosophila Toll pathway exhibit a great deal of similarity to the mammalian MyD88-dependent pathway, which is critical for NF-κB activation downstream of most TLRs.
The IMD pathway
The IMD pathway is potently activated by meso-dia-http://bmbreports.org BMB reports (39, 40) . The role of PGRP-LCy in microbial recognition is still unknown. In adult flies the recognition is more complex; TCT can be recognized by either PGRP-LC or PGRP-LE (34, 41) . As mentioned previously, PGRP-LE lacks a transmembrane domain and a signal peptide, and is likely an intracellular receptor that recognizes small fragments of PGN-like TCT. These small PGN fragments may be able to gain access to PGRP-LE within the cell, while larger polymeric PGNs can only stimulate the cell surface receptor PGRP-LC. In addition to its role as an intracellular receptor, several findings argue that PGRP-LE is also likely to function outside the cell. The PGRP domain of PGRP-LE (PRGP-LE pg ) is found in the hemolymph (the insect sera), and is hypothesized to bind PGN and present it to the cell surface receptor PGRP-LC. This extracellular activity of PGRP-LE is analogous to CD14/LPS interactions in mammals. The mechanism by which PGRP-LE pg is secreted or released from cells is unclear (34, 41) (See Fig. 2 ).
The molecular mechanisms of PGN-induced signaling, by either PGRP-LC or PGRP-LE, are the focus of current research. In vitro, TCT induces the multimerization of PGRP-LE or the heterodimerization of PGRP-LCx and -LCa (42) (43) (44) (45) . These ligand-induced oligomers are likely to be critical for signaling. On the other hand, the structure of PGRP-LCx suggests it does not homodimerize. Therefore, LCx-mediated signaling, following exposure to polyermic PGN, may be due to receptor clustering on this polyvalent ligand.
Once clustered, dimerized or multimerized, these receptors signal via their N-terminal domains (46) . Although they are highly dissimilar, the N-termini of PGRP-LE and PGRP-LC share a short conserved motif that is critical for signaling by either receptor (34) . This motif has weak homology to the RHIM motif, found in proteins critical for the TRIF-dependent pathway in mammalian TLR signaling (47, 48) . Epistasis experiments suggest that the IMD protein functions immediately downstream of PGRP-LC and upstream of all other known members of the pathway. IMD is a death domain protein similar to mammalian receptor interacting protein 1 (RIP1) (49) . IMD co-immunoprecipitates with both PGRP-LC and -LE, but this interaction may not be critical for signaling. PGRP-LC mutants that fail to interact with IMD are still able to support signaling, while mutation of the RHIM-like domain, which prevents signaling, does not affect the IMD interaction (34) . The molecular mechanism of PGRP/RHIM domain-mediated signaling requires more study.
Downstream of PGRP-LC and the IMD protein, signal transduction through the pathway requires Drosophila TAK1 for the activation of the Drosophila IKK complex (50) (51) (52) (53) (54) . The molecular mechanisms involved in signaling from IMD to TAK1 are still unclear, although RNAi-based experiments in cultured cells suggest that ubiquitination may play a key role. Zhou et al. (2005) showed that the E2 ubiquitin conjugating enzyme complex of dUEV1A and Bendless (the Drosophila Ubc13 homolog) functions downstream of IMD yet upstream of TAK1 in the IMD pathway (55) . As Ubc13/Uev1A are known to polymerize K63-polyubiquitin chains, these results suggest that non-degratory K63-ubiquitination is involved in IMD signaling, similar to mammalian NF-κB pathways (55) (56) (57) .
Although the E3 ligase involved in the K63-ubiquitination machinery in IMD signaling remains to be identified, the Drosophila inhibitor of apoptosis protein 2 (dIAP2) is an excellent candidate. dIAP2 was recently identified as an essential component of the IMD pathway (58) (59) (60) (61) (62) . dIAP2 is a RING-fin-http://bmbreports.org ger protein, and this signature E3 motif is required for IMD signaling (58) . The apical caspase DREDD also plays a role in signaling between IMD and TAK1, perhaps functioning as an E3-ligase accessory factor (55, 63) . A K63-polyubiquitinated protein target of Ubc13/Uev1a has yet to be identified in the IMD pathway. Nonetheless, K63 polyubiquitination of this unidentified protein is believed to be critical for activation of the MAPKKK TAK1. TAK1 likely functions in a complex with the Drosophila TAB2 homolog (63, 64) . Drosophila TAB2 includes a highly conserved domain shown to specifically bind K63-polyubuquitin chains (55, 57, 65, 66) . Activation of the TAK1/TAB2 complex leads to the simultaneous induction of two downstream branches of the IMD pathway, which culminate in JNK or NF-κB/Relish activation (52) .
The JNK arm of the IMD pathway is activated by TAK1-mediated signaling to Hemipterous, the Drosophila MKK7/JNKK homolog (67) (68) (69) . Hemipterous then phosphorylates basket (dJNK), which activates Drosophila AP-1. Signaling through the IMD/ JNK pathway has been linked to the up-regulation of wound repair and stress response genes (52, 70 ). Yet, the precise role that JNK signaling plays in the IMD pathway is controversial. Several reports have concluded that JNK signaling is not involved in the up-regulation of AMP gene expression. Instead, AMP gene induction relies entirely on the NF-κB/Relish branch of the IMD pathway (52, 70) , while the JNK pathway may actually be involved in down-modulating AMP expression (71, 72) (see below for more details). On the other hand, two reports argue that the JNK pathway also functions in the induction of AMP gene expression (73, 74) . Clarification of these seemingly contradictory results requires further investigation.
TAK1 is also required for induction of the NF-κB/Relish branch of the IMD pathway, through activation of the Drosophila IKK complex (50, 52, 54) . The Drosophila IKK complex contains two subunits: a catalytic kinase subunit encoded by ird5 (IKKβ) and a regulatory subunit encoded by kenny (IKKγ) (51, 53) . The activated IKK complex can directly phosphorylate Relish, which is a bipartite protein similar to mammalian NF-κB precursors p100 and p105. It contains an N-terminal Rel homology domain (RHD) and an inhibitory IκB domain with six ankyrin repeats that sequester the protein in the cytoplasm. Upon activation, Relish is endoproteolytically cleaved by a caspase, producing an N-terminal RHD transcription factor module that translocates into the nucleus to activate immune genes and a stable C-terminal domain that remains in the cytoplasm (75, 76) . Cleavage of Relish requires the caspase-8-like protein DREDD (77) . Although several lines of evidence suggest DREDD directly cleaves Relish, this has not yet been firmly established. Relish cleavage also requires the Drosophila IKK complex but not dTAK1. Since TAK1 is necessary for the PGNinduced activation of the IKK complex as measured by kinase assays, it is not yet clear how the IKK complex controls Relish. Perhaps Relish cleavage is controlled by the IKK complex independent of its kinase activity.
Many questions remain unanswered about the molecular mechanisms required for IMD signaling. It is clear that DAPtype peptidoglycan is the major activator of this pathway through PGRP-LC and PGRP-LE. It is also well established that many of the components involved are homologous to factors involved in mammalian NF-κB pathways. In particular, the involvement of a RIP1-like molecule, IMD, highlights the similarity to the TNFR and TRIF-dependent TLR pathways. However, more study is required to elucidate the molecular events required for TAK1 activation, Relish cleavage, and the transcriptional activation of AMP genes, all of which occurs very rapidly after PGN recognition.
Down-regulation of immune signaling pathways by PGN digesting enzymes
The PGRP family of proteins are similar in structure to N-acetylmuramoyl-L-alanine amidases (NAMLAA), enzymes that degrade PGN by removing the stem-peptide from the glycan backbone (78) . The PGRP proteins that function as receptors in the IMD and Toll pathways lack a critical cysteine residue that is required for catalysis and thus function only as PGN binding receptors. On the other hand, PGRP-LB, SB1, and PGRP-SC1 encode active amidases, and PGRP-SB2 and -SC2 are predicted amidases (5, 78, 79) . Digestion of PGN with type 2 amidases, like these PGRPs, significantly reduces its immunostimulatory activity (39, 80) . PGRP-LB digests only DAP-type PGN, whereas PGRP-SC digests both DAP-type and Lys-type PGN (11, 78) . Depletion of PGRP-SC1/2 or PGRP-LB by RNAi in vivo leads to markedly higher levels of Diptericin expression following infection. PGRP-LB and PGRP-SC are expressed in the gut epithelium and PGRP-LB regulates the immune reactivity of the gut to ingested bacteria. In the gut, the IMD pathway is activated only when the PGN-degrading activity of PGRP-LB is saturated or inactivated. In addition, RNAi knockdown of PGRP-SC1/2 in infected larvae leads to increased developmental defects and lethality (10) . This further supports the idea that PGNdegrading PGRPs prevent potentially pathological consequences to host tissues resulting from prolonged immune activity. PGRP-LB and PGRP-SC are both targets of IMD signaling (like the AMP genes) and thus form a critical link in a negative feedback loop whereby activation of IMD signaling, by PGN, leads to the production of enzymes that digest the stimulating microbial compounds. Additionally, another report shows that PGRP-SC1 mutants affect Toll signaling and it may also play a role in phagocytosis of S. aureus (81) . Although PGRP-LF is a non-catalytic PGRP, it also seems to play an inhibitory role in immunity. PGRP-LF is a transmembrane receptor but it contains only a 23-amino acid intracellular tail. PGRP-LF encodes two PGRP domains in its extracellular portion, which show different affinities for DAP-type PGN and low affinity towards Lys-type PGN. Depletion of PGRP-LF leads to infection-independent activation of the IMD pathway in cultured cells (82) . http://bmbreports.org BMB reports
Negative regulation in the Toll pathway
In addition to regulation of the upstream serine proteases by the serpin necrotic, the Toll pathway is repressed by an intracellular negative feedback loop. WntD (wnt inhibitor of Dorsal) is a member of the wnt family of ligands. Activation of the Toll pathway leads to the transcription of wntD (83, 84 
Negative regulation in the IMD pathway
The MAPKKK TAK1 plays a critical role in the IMD pathway, serving as the branch point for JNK and NF-κB/Relish activation. In turn, these two modules of the IMD pathway negatively regulate each other. IMD regulates the JNK branch by inducing certain genes, via Relish, that lead to the degradation of dTAK1 (85) . JNK activation is prolonged when the Relish branch of the IMD pathway is inhibited. For example, Tsuda et al. (2006) showed that Plenty of SH3 (POSH) regulates the termination of IMD → JNK signaling. POSH mutant flies exhibit increased mortality following E. coli infection, possibly because of hyperactive immune responses (86) . POSH contains a RING finger, a signature ubiquitin E3-ligase motif, and is auto-ubiquitinated. Also, POSH immunoprecipitates with TAK1 and overexpression of POSH reduces the stability of TAK1. Thus, it is hypothesized that POSH negatively regulates the IMD → JNK pathway by regulating the stability of TAK1 via the ubiquitin/ proteosome degradation pathway. On the other hand, JNK signaling also inhibits Relish-mediated transcriptional activation, via the recruitment of a 'repressosome' to AMP genes, as discussed in more detail below (71, 72) . The IMD pathway may also be inhibited by another E3 protein, known as Dnr1, a conserved protein with an N-terminal ezrin/radixin/moesin domain and a C-terminal RING finger. Dnr1 RNAi stimulated a Dpt-lacZ reporter, even in the absence of immune stimulation, in Drosophila cells. Dnr1 appears to have a complex relationship with the caspase DREDD. On one hand, Dnr1 is believed to function as an inhibitor of DREDD. On the other hand, immune stimulation stabilizes Dnr1, in a DREDD-dependent manner. Therefore, Dnr1 may provide another feedback loop where immune stimulation, via DREDD, promotes accumulation of a DREDD inhibitor (87) . These studies of Dnr1 are limited to cultured cells and require further confirmation in vivo.
Another negative regulator of IMD signaling is Caspar. Interestingly, Caspar is homologous to human Fas associated factor 1 (hFAF1), which associates with various components of the TNF/ NF-κB pathway such as FAS, FADD, caspase-8 and NF-κB (88) (89) (90) . caspar mutant animals show constitutive expression of Diptericin, even in the absence of infection. And, mutation of caspar actually protects animals against mildly pathogenic bacteria (91), unlike several other mutants where hyperactivation of IMD signaling causes hyper-susceptibility to infection (11, 71, 91) . Overexpression of Caspar inhibits AMP gene induction and causes decreased viability after infection with these same mildly pathogenic bacteria. It is hypothesized that Caspar blocks Relish cleavage by interfering with DREDD. Caspar contains two ubiquitin-related domains: a so-called UAS (or UBA) domain and a ubiquitin-like domain (UBx), as well as FAS-and DED-interaction domains, all of which are found in hFAF1. The later two domains may mediate interactions between Caspar and either DREDD or dFADD, but this has not yet been demonstrated. The ubiquitin-related domains suggest that Caspar may regulate protein degradation of IMD pathway components, but this also awaits experimental confirmation.
The possible connection between Dnr1 or Caspar and the Ub/proteasome-mediated degradation of IMD components is reminiscent of an earlier result. Khush et al., (2002) found that mutations in skpA constitutively induce IMD signaling, but not the Toll pathway (92) . SkpA is the homolog of the human Skp1 protein, a subunit of SCF-E3 ubiquitin ligase that targets substrates for K48-polyubiquitination and degradation by the 26S proteasome. Other mutants that also effect the Drosophila SCF component, i.e. slimb and dCullin1, also induce Diptericin expression in the absence of infection. In cells, RNAi targeting skpA or slimb leads to the accumulation of both the full length and cleaved forms of Relish. Therefore, it was hypothesized that SkpA, Slimb and dCullin regulate the IMD pathway by controlling Relish stability. Potentially these SCF-dependent effects could be mediated through Caspar.
Transcriptional regulation of the Drosophila immune response
Proper regulation of NF-κB transcription factors is critical for health. A lack of NF-κB signaling or inappropriate activation of NF-κB can lead to serious conditions such as cancer, (auto) inflammatory diseases or developmental defects. Consequently, animals have evolved complex mechanisms to keep NF-κB, per se, in check once it is activated. For example, the JNK branch of the IMD pathway appears to induce the formation of a repressing complex, the 'repressosome', that inhibits AMP genes.
As mentioned above, the JNK and Relish branches of the IMD pathway are thought to mutually inhibit each other (85) . http://bmbreports.org The down-regulation of the IMD pathway by the JNK pathway involves the transcription factor dAP-1, a well-established target of JNK signaling in flies and mammals (72, 93) . AP-1 functions together with the Drosophila STAT protein, Stat92E, to negatively regulate Relish and AMP gene expression. Stat92E is a transcription factor that is activated by the JAK/STAT pathway. Bacterial infections are known to induce this transcription factor via the production of Unpaired-3 (UPD3), a ligand for the JAK/STAT pathway receptor Domeless. UPD3 production following infection requires IMD → Relish signaling in hemocytes (94) . Several Relish-dependent AMP genes, especially AttA, have AP-1 and Stat92E binding sites, in addition to NF-κB sites, in their promoter/enhancer regions. In some cases the Stat92E site overlaps the Relish binding site. Mutation of the AP1 or Stat92E binding site leads to 3-fold higher levels of an AttA reporter (71) . AP1 and Stat92E bind the AttA promoter cooperatively, with the aid of the HMG protein Dsp1, and then recruit the histone deacetylase dHDAC1 to form a repressosome complex. Flies with reduced levels of Stat92E, Jun (known as Jun-related antigen, Jra, in Drosophila) or Dsp1 induce higher levels of Attacin-A transcript following bacterial infection. Also, these mutants display reduced survival following infection with mildly pathogenic bacteria like E. coli. Heterozygosity for a Relish null allele suppresses these phenotypes, consistent with the idea that the respressosome competes with Relish. For example, Relish is rapidly recruited to the AttA promoter, within 15 minutes of PGN stimulation. But, after longer periods of stimulation, loss of Relish binding is observed while the repressosome shows sustained binding. Repressosome recruitment to the AttA promoter also leads to its hypoacetylation. The repressosome-mediated down regulation of Relish-mediated transcription of AttA is not unique; the AMP genes AttacinB, Cecropin A1, Drosocin and Metchnikowin all show patterns similar to AttA. Thus, the inhibitory affect of the repressosome complex on NF-κB is important for maintaining a balanced immune response (71, 72) .
Tissue specific immune regulation
In most of the studies discussed above, the systemic Drosophila immune response was studied. This response relies primarily on the inducible expression of AMP genes in the fat body, the insect liver. In addition, many studies have also been performed in the immune-responsive Drosophila S2 cell line, which is a hemocyte-derived cell line. However, IMD and Toll signaling also occurs in many other tissues. For example, the Toll pathway plays critical roles in hematopoeitic development and function. The transcription factors DIF and Dorsal are required for hemocyte proliferation and to prevent apoptosis. DIF and Dorsal also contribute to the control of systemic infections by regulating phagocytosis (95) . The IMD pathway is present and functional in almost all epithelial cells. However, the responses in these tissues are not identical to those observed in the fat body (or in cell culture). In particular, the outputs of IMD signaling are significantly modified in the gut.
Although Drosophila harbor a substantial number of resident bacteria in their alimentary tract (96) (97) (98) , AMP genes are not expressed in the gut epithelia of healthy animals. Recent studies have shown that these resident microbes still induce IMD signaling in the gut as assayed by Relish translocation and expression of the PGN-digesting PGRP-LB and -SC proteins. However, other Relish target genes, especially the AMP genes, are mostly silent. Ryu et al. (2008) further showed that the gut-specific inhibition of AMP gene expression is mediated by the homeobox transcription factor Caudal (Cad). Caudal is best known for the critical role it plays in development of the mesoderm and gut (99) . A Caudal-response element, essential for the suppression of CecA expression in the gut, was characterized in the promoter/enhancer region of this AMP gene. Moreover, knockdown of Caudal in the gut by tissue-specific RNAi caused constitutive expression of Cecropin in this tissue. AMP gene expression required IMD signaling components, like TAK1 or DREDD, as well as resident gut bacteria. Germ-free animals showed little or no AMP gene expression, even in the absence of Caudal. Expression of AMP genes in the gut when Caudal expression was knocked down by RNAi, caused a shift in the bacterial populations resident in the gut. In particular, one Acetobacteraceae species was greatly reduced while a Gluconobacter species flourished. The Gluconobacter sp. was http://bmbreports.org BMB reports pathogenic, causing significant gut epithelial apoptosis and reduced survival. These findings not only characterized a novel means of regulating immune signaling in a tissue-specific manner, but also highlight the critical importance that proper immune regulation plays in health and disease, even in the fruit fly (see Fig. 3 ) (98) .
Concluding remarks
Over the last 10 years, the Drosophila immune response, particularly the inducible expression of AMP genes, has been the subject of intense study. This research has led to a detailed,
but not yet complete, understanding of the molecular mechanisms involved in microbial recognition and signal transduction in the innate immune response of insects. In comparison with the many studies examining innate immune recognition and signaling in mammals, a striking degree of evolutionary conservation is apparent. However, a number of clear dissimilarities also emerge. Most notably, Drosophila Toll functions as a cytokine receptor while the mammalian Toll-like Receptors are directly involved with microbial recognition. It will be interesting to learn, in the coming years, how the 200＋ Toll-like receptors in the sea urchin function (100).
More recently, the multiple mechanisms involved in keeping the Drosophila immune response in check have begun to come to light. This review highlights some of these recent findings. Given that it is well established that immune activation in flies has a cost, such as reduced fecundity (101, 102) and hypersensitivity to infection (10, 11, 71, 84, 98) , it is not surprising that multiple negative regulatory circuits control the immune response. Similarly, in mammals innate and adaptive immune responses are held in check by multiple mechanisms in order to prevent inflammatory and autoimmune diseases. Future studies will determine if any of the molecular mechanisms used to control the Drosophila IMD and Toll pathways, as reviewed here, are also used by the mammalian innate immune response, or if some of the previously characterized mechanisms involved in controlling mammalian immunity also function in flies.
